Cargando…
Akutes Leberversagen: Von der Epidemiologie und Pathogenese zur Therapie
Acute liver failure (ALF) is characterized by loss of liver function without pre-existing chronic liver disease. Drug toxicity and viral hepatitis have been identified as the main causes of ALF in Germany. The regeneration capability of the liver and overall prognosis are determined by the underlyin...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101637/ https://www.ncbi.nlm.nih.gov/pubmed/32287644 http://dx.doi.org/10.1007/s00390-009-0153-x |
_version_ | 1783511666012454912 |
---|---|
author | Koch , A. Trautwein, C. |
author_facet | Koch , A. Trautwein, C. |
author_sort | Koch , A. |
collection | PubMed |
description | Acute liver failure (ALF) is characterized by loss of liver function without pre-existing chronic liver disease. Drug toxicity and viral hepatitis have been identified as the main causes of ALF in Germany. The regeneration capability of the liver and overall prognosis are determined by the underlying etiology. Advances in intensive care medicine, supportive therapy, and transplantation surgery have improved the overall outcome of ALF over the last two decades. The clinical syndrome of ALF is mainly due to a release of inflammatory cytokines from necrotic hepatocytes, which lead to disastrous consequences in the immune system and hemodynamics. The main goals of supportive intensive care therapy in ALF are early identification and treatment of infections and the prevention and therapy of cerebral hypertension. |
format | Online Article Text |
id | pubmed-7101637 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-71016372020-03-31 Akutes Leberversagen: Von der Epidemiologie und Pathogenese zur Therapie Koch , A. Trautwein, C. Intensivmed Notfallmed Leitthema Acute liver failure (ALF) is characterized by loss of liver function without pre-existing chronic liver disease. Drug toxicity and viral hepatitis have been identified as the main causes of ALF in Germany. The regeneration capability of the liver and overall prognosis are determined by the underlying etiology. Advances in intensive care medicine, supportive therapy, and transplantation surgery have improved the overall outcome of ALF over the last two decades. The clinical syndrome of ALF is mainly due to a release of inflammatory cytokines from necrotic hepatocytes, which lead to disastrous consequences in the immune system and hemodynamics. The main goals of supportive intensive care therapy in ALF are early identification and treatment of infections and the prevention and therapy of cerebral hypertension. Springer-Verlag 2010-04-23 2010 /pmc/articles/PMC7101637/ /pubmed/32287644 http://dx.doi.org/10.1007/s00390-009-0153-x Text en © Springer-Verlag 2010 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Leitthema Koch , A. Trautwein, C. Akutes Leberversagen: Von der Epidemiologie und Pathogenese zur Therapie |
title | Akutes Leberversagen: Von der Epidemiologie und Pathogenese zur Therapie |
title_full | Akutes Leberversagen: Von der Epidemiologie und Pathogenese zur Therapie |
title_fullStr | Akutes Leberversagen: Von der Epidemiologie und Pathogenese zur Therapie |
title_full_unstemmed | Akutes Leberversagen: Von der Epidemiologie und Pathogenese zur Therapie |
title_short | Akutes Leberversagen: Von der Epidemiologie und Pathogenese zur Therapie |
title_sort | akutes leberversagen: von der epidemiologie und pathogenese zur therapie |
topic | Leitthema |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101637/ https://www.ncbi.nlm.nih.gov/pubmed/32287644 http://dx.doi.org/10.1007/s00390-009-0153-x |
work_keys_str_mv | AT kocha akutesleberversagenvonderepidemiologieundpathogenesezurtherapie AT trautweinc akutesleberversagenvonderepidemiologieundpathogenesezurtherapie |